Text Size

Multimodal Music Therapy for Children With Anxiety Disorders

This study has been completed.
Sponsor:
Information provided by:
University of Ulm
ClinicalTrials.gov Identifier:
NCT01062646
First received: February 3, 2010
Last updated: NA
Last verified: May 2006
History: No changes posted
  Purpose

Multimodal music therapy (MT) for children ages 8 to 12 years with anxiety disorders is compared to community treatment as usual (TAU). 36 children were randomized either to MT or to TAU. Primary outcome is presence of an anxiety disorder at the end of treatment. Secondary outcomes are self- and parent-/teacher reported anxiety, co-morbid psychological symptoms, and quality of life. Stability of outcome is assessed six months after the end of treatment.


Condition Intervention Phase
Anxiety
 Behavioral: Multimodal music therapy
Behavioral: Community treatment as usual
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial of Multimodal Music Therapy for Children With Anxiety Disorders

Resource links provided by NLM:

MedlinePlus related topics: Anxiety
U.S. FDA Resources

Further study details as provided by University of Ulm:

Primary Outcome Measures:
  • Diagnosis of an anxiety disorder (DSM IV)

Enrollment: 36
Study Start Date: May 2006
Study Completion Date: September 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Multimodal music therapy
Multimodal music therapy comprises 16 sessions single music therapy, group music therapy (max. 6 children/group), parent-child sessions, and parent counseling. The manualized treatment integrates music therapy, behavioral interventions, and family-oriented interventions.
 Behavioral: Multimodal music therapy
Active Comparator: community treatment as usual Behavioral: Community treatment as usual

Detailed Description:

Patients were enrolled in a community clinic and in an outpatient clinic for child and adolescent psychiatry/psychotherapy. Inclusion criteria: diagnosis of an anxiety disorder (separation anxiety disorder, general anxiety disorder, social phobia, specific phobia, or other anxiety disorder); age 8-12; no medication or stable medication during treatment; IQ>80; informed consent of caregivers and informed assent of patients. Outcome measures. Kiddie-SADS; STAIC-C, SPAIC, CDI; SDQ teacher report; CBCL 4-18; ILK quality of life inventory. Assessment time points: pre-intervention; post-intervention; 6-months follow-up.

  Eligibility

Ages Eligible for Study:   8 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 8-12 years
  • diagnosis of an anxiety disorder
  • IQ>80
  • informed consent and assent

Exclusion Criteria:

  • anxiety disorder is not primary focus of treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01062646

Sponsors and Collaborators
University of Ulm
Investigators
Principal Investigator: Lutz Goldbeck, Ph.D. University Ulm
  More Information

No publications provided

Responsible Party: Prof. Dr. Goldbeck, University Ulm
ClinicalTrials.gov Identifier: NCT01062646     History of Changes
Other Study ID Numbers: MUSICANXCHILD
Study First Received: February 3, 2010
Last Updated: February 3, 2010
Health Authority: Germany: Ethics Commission

Keywords provided by University of Ulm:
music therapy
multimodal psychotherapy
children
anxiety disorders
pediatric anxiety

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013